Vasculitis

1 paper

In silico1

Trial sponsors

Assistance Publique - Hôpitaux de Paris
2 trialsPhase 4161 people
University Medical Center Groningen
1 trialPhase 384 people
Assiut University
1 trialPhase 370 people
University of South Florida
1 trialPhase 312 people
National Institute of Allergy and Infectious Diseases
2 trialsPhase 2/3297 people
Cambridge University Hospitals NHS Foundation Trust
1 trialPhase 2/3140 people
Northwestern University
2 trialsPhase 213 people
Charite University, Berlin, Germany
1 trialPhase 210 people

Latest

3 in 12 months

Ageing Research Reviews8 Oct

Is there a role for senotherapeutics in the treatment of giant cell arteritis?

ReviewInterventions

Genetics Research24 Aug

Impact of Infection-Related Immune Responses on ANCA-Associated Vasculitis in Finns: A Mendelian Randomization Study

Mendelian randomisation in peopleImmune response

Drugs15 Feb

More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases

ReviewSGLT2 inhibitors

Aging and Disease3 Sep

Cross-Trait Meta-Analysis Reveals a Genetic Link between Inflammation and Aging in Giant Cell Arteritis

Computational studyInflammation

Nature Aging15 Aug

Sustained immune youth risks autoimmune disease in the aging host

ReviewMechanisms